Avidity Biosciences
RNAM
#1892
Rank
A$16.20 B
Marketcap
A$104.88
Share price
0.00%
Change (1 day)
135.70%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: A$16.20 Billion

As of July 2026 Avidity Biosciences has a market cap of A$16.20 Billion. This makes Avidity Biosciences the world's 1892th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026A$16.20 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$199.64 B 1,132.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$154.78 B 855.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$2.93 B-81.91%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$9.95 B-38.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.49 B-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.18 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.74 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$5.54 B-65.77%๐Ÿ‡บ๐Ÿ‡ธ USA